Aspira Women's Health Inc.
AWHL· OTC
Released Nov 14, 2013, after the close
10-Q filed Nov 14, 2013, 45 days after period end · 0000926617-13-000031
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $330.00K | $319.00K | $320.00K | $413.00K |
| Net Income | -$2.31M | -$2.02M | -$4.65M | -$2.74M |
| EPS Diluted | -$0.10 |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.13 |
| -$0.31 |
| -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.